Actos Bladder Cancer Link: Whistleblower Says Takeda Knew
A former researcher and safety consultant for the drug company Takeda filed a whistleblower lawsuit alleging that Takeda misled the FDA about bladder cancer and Congestive Heart Failure (CHF) risks associated with the diabetes drug Actos. The whistleblower lawsuit was filed by Dr. Helen Ge, a former associate medical director at the Harvard Clinical Research Institute. The lawsuit says that Takeda grossly underreported known incidents of CHF and bladder cancer in patients taking Actos so that the drug would out perform competitors. The complaint states that Takeda misled the FDA in order to “falsely enhance Actos’ safety profile and to increase sales.”
Actos Drug Maker Hides the True Risk of Bladder Cancer
The lawsuit claims that Dr. Ge was repeatedly warned by Takeda officials to change her opinions about the adverse side effects of Actos. The complaint states that Takeda placed profits above the safety of patients and stood to make billions of dollars in additional revenue by withholding the truth. FDA rules required Takeda to accurately report adverse events. If Takeda had followed the rules, Dr. Ge says that warnings about CHF and bladder cancer would have been included with the drug earlier. Dr. Ge says she was eventually fired for speaking the truth.
The Actos lawyers at Bailey & Greer represent people from all across the country who have been diagnosed with bladder cancer while taking Actos. Call us today at 901-680-9777 for a free consultation.
Since graduating magna cum laude in 2005 from the University of Memphis School of Law, Thomas has helped make a difference in the lives of victims of serious personal injury, wrongful death, and professional negligence. Thomas has extensive trial experience in both state and federal court. Among other victories in the courtroom, Thomas obtained several impressive jury verdicts and settlements
Read more about Thomas R. Greer